Nouveau Life Pharmaceuticals, Inc. (NOUV)

Other OTC - Other OTC Delayed Price. Currency in USD

0.0002

0.0000

(0.00%)

At close: 03:48PM EST

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.0002
Open	0.0001
Bid	0.0000 x 0
Ask	0.0000 x 0
Day's Range	0.0001 - 0.0003
52 Week Range	0.0001 - 0.0004
Volume	40,340,372
Avg. Volume	6,093,823

Market Cap	969,597
Beta (5Y Monthly)	-3.80
PE Ratio (TTM)	N/A
EPS (TTM)	-0.0000
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for NOUV

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

NOUVEAU LIFE PHARMACEUTICALS IN
Analyst Report: Donaldson Company, Inc.Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.4 billion in revenue and $480 million in operating income in its fiscal 2023.
Rating
Fair Value
Economic Moat
4 days agoMorningstar